Tevogen Bio Inc. (TVGNW)
0.07
0.00 (0.00%)
At close: Jan 14, 2025, 2:59 PM
0.07
0.00%
After-hours Jan 14, 2025, 02:59 PM EST
undefined% (undefined)
| Bid | 0.01 |
| Market Cap | 264.34M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 57,154 |
| Avg. Volume (20D) | 0 |
| Open | 0.07 |
| Previous Close | 0.07 |
| Day's Range | 0.07 - 0.07 |
| 52-Week Range | 0.07 - 0.07 |
| Beta | undefined |
About TVGNW
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey....
Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 17
Stock Exchange NASDAQ
Ticker Symbol TVGNW
Website https://tevogen.com